Disulfide stabilized foldon polypeptides

US9550813B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9550813-B2
Application numberUS-201314401754-A
CountryUS
Kind codeB2
Filing dateMay 22, 2013
Priority dateMay 22, 2012
Publication dateJan 24, 2017
Grant dateJan 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Intermolecular disulfide stabilized foldon polypeptides are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A cysteine-substituted foldon polypeptide, wherein two amino acids of a native foldon polypeptide are substituted with cysteine residues that can form intermolecular disulfide bonds when the foldon is in a trimeric quaternary structure, wherein the native foldon polypeptide has the amino acid sequence set forth in SEQ ID NO:1 and wherein the amino acid substitutions are selected from [G10C, D17C]; [R8C, D17C]; [R8C, G18C]; [P7C, G18C]; [A12C, K16C]; and [Y13C, R15C]. 2. The cysteine-substituted foldon polypeptide of claim 1 , wherein the amino acid substitutions are selected from [A12C, K16C]; [R8C, D17C]; and [R8C, G18C]. 3. The cysteine-substituted foldon polypeptide of claim 1 , wherein the cysteine-substituted foldon polypeptide is a monomer. 4. The cysteine-substituted foldon polypeptide of claim 1 , wherein the cysteine-substituted foldon polypeptide is a trimer. 5. The cysteine-substituted foldon polypeptide of claim 1 , wherein the cysteine-substituted foldon polypeptide is joined to a fusion partner. 6. The cysteine-substituted foldon polypeptide of claim 5 , wherein the fusion partner is a viral antigen. 7. The cysteine-substituted foldon polypeptide of claim 1 , further comprising one or more of a tag for purification, an unnatural amino acid, and site for protease cleavage. 8. The cysteine-substituted foldon polypeptide of claim 7 , wherein the cysteine-substituted foldon polypeptide is a fusion protein, and comprises at least one unnatural amino acid at a defined site. 9. The cysteine-substituted foldon polypeptide of claim 8 , where the cysteine-substituted foldon polypeptide is a trimer, and the unnatural amino acid is used to covalently join one chain of the trimer to a virus like particle. 10. A method of producing a cysteine-substituted foldon polypeptide according to claim 1 , comprising introducing a polynucleotide sequence encoding the cysteine-substituted foldon polypeptide operably linked to a promoter, into a cell or cell free protein synthesis reaction mix and incubating for a period of time sufficient to synthesize the protein.

Assignees

Inventors

Classifications

  • containing protease site · CPC title

  • New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title

  • containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin · CPC title

  • New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title

  • containing a Strep-tag · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9550813B2 cover?
Intermolecular disulfide stabilized foldon polypeptides are provided.
Who is the assignee on this patent?
Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification C07K14/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).